Viewing Study NCT02249702


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-02-22 @ 12:58 AM
Study NCT ID: NCT02249702
Status: COMPLETED
Last Update Posted: 2017-12-06
First Post: 2014-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma
Sponsor: Mario Negri Institute for Pharmacological Research
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leiomyosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None trabectedin View
None uterine leiomyosarcoma View